Onofrio, L. I., Alamino, V. A., Ferrero, P. V., Montes, C. L., Gruppi, A., Acosta Rodriguez, E. V., . . . Cadile, I. I. (2022). The JAK inhibitor tofacitinib activates immunosenescence pathways and limits activation and function of T lymphocytes. Web
Citación estilo ChicagoOnofrio, Luisina Ines, Vanina Alejandra Alamino, Paola Virginia Ferrero, Carolina Lucía Montes, Adriana Gruppi, Eva Virginia Acosta Rodriguez, Marina Werner, Laura Beatriz Onetti, and Isaac Ignacio Cadile. The JAK Inhibitor Tofacitinib Activates Immunosenescence Pathways and Limits Activation and Function of T Lymphocytes. 2022.
Cita MLAOnofrio, Luisina Ines, et al. The JAK Inhibitor Tofacitinib Activates Immunosenescence Pathways and Limits Activation and Function of T Lymphocytes. 2022.